Urinary Interleukin-18 Is a Marker of Human Acute Tubular Necrosis

Chirag Parikh, Alkesh Jani, Vyacheslav Y. Melnikov, Sarah Faubel, Charles L. Edelstein

Research output: Contribution to journalArticle

Abstract

Background: Interleukin-18 (IL-18) is a mediator of ischemic acute tubular necrosis (ATN) in mice. Methods: IL-18 was measured in human urine to determine whether it might serve as a marker of ATN. Seventy-two patients, including healthy controls, patients with different forms of acute renal failure, and patients with other renal diseases, were studied. Results: Patients with ATN had significantly greater median urinary IL-18 concentrations than those with all other conditions: patients with ATN, 644 pg/mg creatinine (mean, 814 ± 151 [SE] pg/mg creatinine; P <0.0001) versus healthy controls, 16 pg/mg creatinine (mean, 23 ± 9 pg/mg creatinine); patients with prerenal azotemia, 63 pg/mg creatinine (mean, 155 ± 68 pg/mg creatinine); patients with urinary tract infection, 63 pg/mg creatinine (mean, 149 ± 110 pg/mg creatinine); those with chronic renal insufficiency, 12 pg/mg creatinine (mean, 84 ± 45 pg/mg creatinine); and patients with nephrotic syndrome, 34 pg/mg creatinine (mean, 67 ± 47 pg/mg creatinine). Median urinary IL-18 concentrations measured in the first 24 hours after kidney transplantation were 924 pg/mg creatinine (mean, 1,199 ± 187 pg/mg creatinine) in patients who received a cadaveric kidney that developed delayed graft function compared with 171 pg/mg creatinine (mean, 367 ± 102 pg/mg creatinine) in patients who received a cadaveric kidney with prompt graft function and 73 pg/mg creatinine (mean, 176 ± 107 pg/mg creatinine) in patients who received a kidney with prompt graft function from a living donor (P <0.002). In kidney transplant recipients, lower urinary IL-18 levels were associated with a steeper decline in serum creatinine concentrations postoperative days 0 to 4 (P = 0.009). Conclusion: IL-18 levels are elevated in urine in patients with ATN and delayed graft function compared with other renal diseases. Urinary IL-18 may serve as a marker for proximal tubular injury in ATN. The clinical application of this test may be substantial because it is reliable, inexpensive, and easy to perform.

Original languageEnglish (US)
Pages (from-to)405-414
Number of pages10
JournalAmerican Journal of Kidney Diseases
Volume43
Issue number3
DOIs
StatePublished - Jan 1 2004
Externally publishedYes

Fingerprint

Interleukin-18
Creatinine
Necrosis
Kidney
Delayed Graft Function
Urine
Azotemia
Transplants

Keywords

  • Acute tubular necrosis (ATN)
  • Delayed graft function
  • Interleukin-18 (IL-18)
  • Urine

ASJC Scopus subject areas

  • Nephrology

Cite this

Urinary Interleukin-18 Is a Marker of Human Acute Tubular Necrosis. / Parikh, Chirag; Jani, Alkesh; Melnikov, Vyacheslav Y.; Faubel, Sarah; Edelstein, Charles L.

In: American Journal of Kidney Diseases, Vol. 43, No. 3, 01.01.2004, p. 405-414.

Research output: Contribution to journalArticle

Parikh, Chirag ; Jani, Alkesh ; Melnikov, Vyacheslav Y. ; Faubel, Sarah ; Edelstein, Charles L. / Urinary Interleukin-18 Is a Marker of Human Acute Tubular Necrosis. In: American Journal of Kidney Diseases. 2004 ; Vol. 43, No. 3. pp. 405-414.
@article{c168c028aa9644d78b8634f5c068d68b,
title = "Urinary Interleukin-18 Is a Marker of Human Acute Tubular Necrosis",
abstract = "Background: Interleukin-18 (IL-18) is a mediator of ischemic acute tubular necrosis (ATN) in mice. Methods: IL-18 was measured in human urine to determine whether it might serve as a marker of ATN. Seventy-two patients, including healthy controls, patients with different forms of acute renal failure, and patients with other renal diseases, were studied. Results: Patients with ATN had significantly greater median urinary IL-18 concentrations than those with all other conditions: patients with ATN, 644 pg/mg creatinine (mean, 814 ± 151 [SE] pg/mg creatinine; P <0.0001) versus healthy controls, 16 pg/mg creatinine (mean, 23 ± 9 pg/mg creatinine); patients with prerenal azotemia, 63 pg/mg creatinine (mean, 155 ± 68 pg/mg creatinine); patients with urinary tract infection, 63 pg/mg creatinine (mean, 149 ± 110 pg/mg creatinine); those with chronic renal insufficiency, 12 pg/mg creatinine (mean, 84 ± 45 pg/mg creatinine); and patients with nephrotic syndrome, 34 pg/mg creatinine (mean, 67 ± 47 pg/mg creatinine). Median urinary IL-18 concentrations measured in the first 24 hours after kidney transplantation were 924 pg/mg creatinine (mean, 1,199 ± 187 pg/mg creatinine) in patients who received a cadaveric kidney that developed delayed graft function compared with 171 pg/mg creatinine (mean, 367 ± 102 pg/mg creatinine) in patients who received a cadaveric kidney with prompt graft function and 73 pg/mg creatinine (mean, 176 ± 107 pg/mg creatinine) in patients who received a kidney with prompt graft function from a living donor (P <0.002). In kidney transplant recipients, lower urinary IL-18 levels were associated with a steeper decline in serum creatinine concentrations postoperative days 0 to 4 (P = 0.009). Conclusion: IL-18 levels are elevated in urine in patients with ATN and delayed graft function compared with other renal diseases. Urinary IL-18 may serve as a marker for proximal tubular injury in ATN. The clinical application of this test may be substantial because it is reliable, inexpensive, and easy to perform.",
keywords = "Acute tubular necrosis (ATN), Delayed graft function, Interleukin-18 (IL-18), Urine",
author = "Chirag Parikh and Alkesh Jani and Melnikov, {Vyacheslav Y.} and Sarah Faubel and Edelstein, {Charles L.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1053/j.ajkd.2003.10.040",
language = "English (US)",
volume = "43",
pages = "405--414",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Urinary Interleukin-18 Is a Marker of Human Acute Tubular Necrosis

AU - Parikh, Chirag

AU - Jani, Alkesh

AU - Melnikov, Vyacheslav Y.

AU - Faubel, Sarah

AU - Edelstein, Charles L.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Background: Interleukin-18 (IL-18) is a mediator of ischemic acute tubular necrosis (ATN) in mice. Methods: IL-18 was measured in human urine to determine whether it might serve as a marker of ATN. Seventy-two patients, including healthy controls, patients with different forms of acute renal failure, and patients with other renal diseases, were studied. Results: Patients with ATN had significantly greater median urinary IL-18 concentrations than those with all other conditions: patients with ATN, 644 pg/mg creatinine (mean, 814 ± 151 [SE] pg/mg creatinine; P <0.0001) versus healthy controls, 16 pg/mg creatinine (mean, 23 ± 9 pg/mg creatinine); patients with prerenal azotemia, 63 pg/mg creatinine (mean, 155 ± 68 pg/mg creatinine); patients with urinary tract infection, 63 pg/mg creatinine (mean, 149 ± 110 pg/mg creatinine); those with chronic renal insufficiency, 12 pg/mg creatinine (mean, 84 ± 45 pg/mg creatinine); and patients with nephrotic syndrome, 34 pg/mg creatinine (mean, 67 ± 47 pg/mg creatinine). Median urinary IL-18 concentrations measured in the first 24 hours after kidney transplantation were 924 pg/mg creatinine (mean, 1,199 ± 187 pg/mg creatinine) in patients who received a cadaveric kidney that developed delayed graft function compared with 171 pg/mg creatinine (mean, 367 ± 102 pg/mg creatinine) in patients who received a cadaveric kidney with prompt graft function and 73 pg/mg creatinine (mean, 176 ± 107 pg/mg creatinine) in patients who received a kidney with prompt graft function from a living donor (P <0.002). In kidney transplant recipients, lower urinary IL-18 levels were associated with a steeper decline in serum creatinine concentrations postoperative days 0 to 4 (P = 0.009). Conclusion: IL-18 levels are elevated in urine in patients with ATN and delayed graft function compared with other renal diseases. Urinary IL-18 may serve as a marker for proximal tubular injury in ATN. The clinical application of this test may be substantial because it is reliable, inexpensive, and easy to perform.

AB - Background: Interleukin-18 (IL-18) is a mediator of ischemic acute tubular necrosis (ATN) in mice. Methods: IL-18 was measured in human urine to determine whether it might serve as a marker of ATN. Seventy-two patients, including healthy controls, patients with different forms of acute renal failure, and patients with other renal diseases, were studied. Results: Patients with ATN had significantly greater median urinary IL-18 concentrations than those with all other conditions: patients with ATN, 644 pg/mg creatinine (mean, 814 ± 151 [SE] pg/mg creatinine; P <0.0001) versus healthy controls, 16 pg/mg creatinine (mean, 23 ± 9 pg/mg creatinine); patients with prerenal azotemia, 63 pg/mg creatinine (mean, 155 ± 68 pg/mg creatinine); patients with urinary tract infection, 63 pg/mg creatinine (mean, 149 ± 110 pg/mg creatinine); those with chronic renal insufficiency, 12 pg/mg creatinine (mean, 84 ± 45 pg/mg creatinine); and patients with nephrotic syndrome, 34 pg/mg creatinine (mean, 67 ± 47 pg/mg creatinine). Median urinary IL-18 concentrations measured in the first 24 hours after kidney transplantation were 924 pg/mg creatinine (mean, 1,199 ± 187 pg/mg creatinine) in patients who received a cadaveric kidney that developed delayed graft function compared with 171 pg/mg creatinine (mean, 367 ± 102 pg/mg creatinine) in patients who received a cadaveric kidney with prompt graft function and 73 pg/mg creatinine (mean, 176 ± 107 pg/mg creatinine) in patients who received a kidney with prompt graft function from a living donor (P <0.002). In kidney transplant recipients, lower urinary IL-18 levels were associated with a steeper decline in serum creatinine concentrations postoperative days 0 to 4 (P = 0.009). Conclusion: IL-18 levels are elevated in urine in patients with ATN and delayed graft function compared with other renal diseases. Urinary IL-18 may serve as a marker for proximal tubular injury in ATN. The clinical application of this test may be substantial because it is reliable, inexpensive, and easy to perform.

KW - Acute tubular necrosis (ATN)

KW - Delayed graft function

KW - Interleukin-18 (IL-18)

KW - Urine

UR - http://www.scopus.com/inward/record.url?scp=1542287608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542287608&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2003.10.040

DO - 10.1053/j.ajkd.2003.10.040

M3 - Article

C2 - 14981598

AN - SCOPUS:1542287608

VL - 43

SP - 405

EP - 414

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 3

ER -